Drreddys Laboratories | RDY - Betriebsaufwand





Betriebsaufwand Veränderung Datum
ANI Pharmaceuticals USD 637.11M 39.9M 2026-09
Aurora Cannabis CAD 76.28M 28.24M 2026-06
Bayer EUR 9.92B 121M 2026-09
Canopy Growth CAD 98.74M 23K 2026-06
Cipla INR 63.61B 1.3B 2026-09
Corcept Therapeutics USD 225.75M 10.9M 2026-09
Drreddys Laboratories INR 73.9B 431M 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lonza CHF 2.9B 184M 2025-06
Novartis USD 9.88B 325M 2026-09
Pacira USD 1.18B 995.96M 2026-09
Phibro Animal Health USD 417.67M 1.04B 2026-09
Prestige Brands USD 213.19M 7.06M 2026-06
Richter Gedeon HUF 165.23B 7.35B 2026-06
Sun Pharmaceuticals INR 122.92B 5.49B 2026-09
Supernus Pharmaceuticals USD 1.06B 31.25M 2026-09
Teva Pharmaceutical Industries USD 3.18B 733M 2026-09